Corcept Therapeutics
CORT
CORT
62 hedge funds and large institutions have $102M invested in Corcept Therapeutics in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
37% less capital invested
Capital invested by funds: $161M → $102M (-$59.1M)
Holders
62
Holding in Top 10
1
Calls
$91K
Puts
$25K
Top Buyers
| 1 | +$3.09M | |
| 2 | +$1.51M | |
| 3 | +$436K | |
| 4 |
Goldman Sachs
New York
|
+$379K |
| 5 |
State Street
Boston,
Massachusetts
|
+$312K |
Top Sellers
| 1 | -$9.38M | |
| 2 | -$981K | |
| 3 | -$443K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$362K |
| 5 |
Barclays
London,
United Kingdom
|
-$227K |